Skip to main content

Peer Review reports

From: How effective is the BNT162b2 mRNA vaccine against SARS-CoV-2 transmission and infection? A national programme analysis in Monaco, July 2021 to September 2022

Original Submission
11 Dec 2023 Submitted Original manuscript
24 Jan 2024 Reviewed Reviewer Report
20 Feb 2024 Reviewed Reviewer Report
28 Feb 2024 Reviewed Reviewer Report
3 Apr 2024 Author responded Author comments - Thomas Althaus
Resubmission - Version 2
3 Apr 2024 Submitted Manuscript version 2
7 Apr 2024 Reviewed Reviewer Report
7 Apr 2024 Reviewed Reviewer Report
8 May 2024 Author responded Author comments - Thomas Althaus
Resubmission - Version 3
8 May 2024 Submitted Manuscript version 3
13 May 2024 Author responded Author comments - Thomas Althaus
Resubmission - Version 4
13 May 2024 Submitted Manuscript version 4
21 May 2024 Author responded Author comments - Thomas Althaus
Resubmission - Version 5
21 May 2024 Submitted Manuscript version 5
Publishing
24 May 2024 Editorially accepted
5 Jun 2024 Article published 10.1186/s12916-024-03444-6

You can find further information about peer review here.

Back to article page